Atrial fibrillation (AF) is one of the most common cardiac conditions treated in primary care
and specialty cardiology settings, and is associated with considerable morbidity, mortality …

The use of catheter ablation to treat AF is increasing rapidly, but there is presently an
incomplete understanding of its cost-effectiveness. AF ablation procedures involve …

Atrial fibrillation (AF) is a common and frequently disabling chronic condition associated with
significant patient morbidity and affecting an increasing stratum of our ageing society. Direct …

Background A health technology assessment (HTA) of catheter ablation for atrial fibrillation
(CA-AF) was commissioned by the Belgian government and performed by the Belgian …

The real-world outcomes of atrial fibrillation ablation are sobering. Confirmation of these
findings with prospective, population-based, minimally biased studies is needed. There is a …

Randomised evidence supports an early rhythm control strategy as treatment for AF, and
catheter ablation outperforms medical therapy in terms of effectiveness when studied as first …

Introduction Research evidence has shown that catheter ablation is a safe and superior
treatment for atrial fibrillation (AF) compared to medical therapy, but real‐world practice has …

Background: In the CABANA trial (Catheter Ablation vs Antiarrhythmic Drug Therapy for
Atrial Fibrillation), catheter ablation did not significantly reduce the primary end point of …

Radiofrequency catheter ablation has become an established treatment option for the
management of patients with atrial fibrillation (AF). Although the concept of a rhythm control …

Background: Atrial Fibrillation is the most common cardiac arrhythmia. It increases the risk of
thromboembolic events and many atrial fibrillation patients suffer quality of life impairment …